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Identiﬁcation of critical base pairs required
for CTCF binding in motif M1 and M2
Dear Editor,
The ubiquitously expressed CCCTC-binding factor (CTCF),
is highly conserved from Drosophila to mammals and plays
multiple functions in the genome (Ohlsson et al., 2001).
CTCF has been shown to establish chromatin insulation in
vertebrate, and it also plays the roles in transcriptional reg-
ulation, X-chromosome inactivation, and imprinting of genes
(Phillips and Corces, 2009). In addition, CTCF plays a pivotal
role in genomic organization and loop formation by mediat-
ing long-range chromatin interactions between distant loci
(Yao et al., 2010; Tang et al., 2015). Several hypotheses
have been proposed to explain the diverse functions of
CTCF. The popular ‘zinc-ﬁnger model’ proposed that the
CTCF’s different functions are due to the interplay between
the zinc-ﬁnger engagement and the underlying sequence
differences (Ohlsson et al., 2001). Genome-wide studies
have identiﬁed that the majority of CTCF binding sites
belongs to a set of nonpalindromic CTCF binding sites with a
consensus sequence referred to as M1 (Kim et al., 2007;
Schmidt et al., 2012). Recently, another binding motif,
referred to as M2 and 5–6 bp upstream of M1, has been
discovered (Schmidt et al., 2012). Moreover, CTCF zinc
ﬁngers (ZFs) 4–8 strongly bind to the M1, while ZFs 7–11
tend to strongly bind to the M2 (Renda et al., 2007; Xiao
et al., 2015). In this study, we aim to compare the binding
abilities of CTCF to M1 and M2 and determine which bases
were requirement for M1 and M2 bind to CTCF.
To investigate the binding capacities of CTCF-ZFs 1–11 to
M1 or M2, pGEX-4T-2-CTCF-ZFs plasmid was constructed
to induce the prokaryotic expression of GST-CTCF-ZFs
(Fig. S1A). We tested three traditional temperature condi-
tions (16°C, 28°C, and 37°C) and four IPTG concentrations
(0.1 mmol/L, 0.5 mmol/L, 1 mmol/L, and 1.5 mmol/L). Coo-
massie blue staining results showed that GST-CTCF-ZFs
was robustly induced at 28°C with an obvious band at about
55 kDa (Fig. S1B). We further optimized the IPTG concen-
tration and found that the most suitable IPTG concentration
for inducing GST-CTCF-ZFs expression was 0.6–0.7 mmol/L
(Fig. S1C). Therefore, we concluded that the optimized
induction condition for GST-CTCF-ZFs was 28°C with IPTG
at a concentration between 0.6 and 0.7 mmol/L. GST-CTCF-
ZFs was puriﬁed by using glutathione resin, eluted by using
reduced glutathione and stained with reduced glutathione
(Fig. S1D) and used for subsequent electrophoretic mobility
shift assay (EMSA) experiments.
Next we synthesized two DNA oligos, containing the
CTCF binding sites M1 and M2 (Fig. 1A and 1D). Our
EMSA results indicated that 20 fmol biotin-labeled M1
could bind to 0.2 μg in vitro puriﬁed GST-CTCF-ZFs and
lead to a supershift band (Fig. 1B). The binding of M1 to
GST-CTCF-ZFs became stronger with the increased
amount of GST-CTCF-ZFs from 0.2 μg to 2.5 μg (Fig. 1B).
When the amount of GST-CTCF-ZFs increases to 1.5 μg,
free DNA duplex was barely observed. To further examine
the binding speciﬁcity, we performed EMSA with the
competition of excessive amounts of unlabeled M1 DNA
oligos. Our results demonstrated that the binding of puri-
ﬁed GST-CTCF-ZFs to the biotin-labeled M1 oligo was
competed by an excess amount of the unlabeled M1 oligo
(Fig. 1C, lane 4).
Compared with that of M1, the binding of M2 to puriﬁed
GST-CTCF-ZFs protein was much weaker (Fig. 1E). No
protein/DNA supershift was observed when the amount of
GST-CTCF-ZFs in protein/DNA complex is between
0.2–0.4 μg (Fig. 1E, lanes 2 and 3). The supershift band
gradually became stronger with the increased amount of
GST-CTCF-ZFs from 0.6 μg to 2.5 μg (Fig. 1E). We further
conﬁrmed that the interaction between GST-CTCF-ZFs and
the biotin-labeled M2 oligo was abolished by an excess
amount of the unlabeled M2 oligos (Fig. 1F).
To quantify the strength of CTCF-ZF’s interaction with
M1 and M2, we performed EMSA assays to determine
the dissociation constant (Kd) for CTCF-DNA interactions.
The strong CTCF binding motif, M1 demonstrated a Kd of
1.0 × 10−11 mol/L contrasting with Kd values of
2.9 × 10−10 mol/L for CTCF-M2 interactions (Fig. 1G and
1H). Based on the amount of GST-CTCF-ZFs used in the
EMSA assay and Kd values, we hypothesized that,
compared with the binding of M1 to GST-CTCF-ZFs, the
binding of M2 to GST-CTCF-ZFs was much weaker
(Fig. 1B–H). To test this hypothesis, we did two compe-
tition experiments that use unlabeled M1 or M2 to com-
pete biotin-labeled M2 or M1. Our data indicated that the
unlabeled M1 speciﬁcally and nearly completely displaced
M2 binding at 100-fold excess, whereas an unlabeled M2
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Figure 1. CTCF-ZFs bind to M1 stronger than to M2. (A) The sequences of CTCF binding motif M1. (B) Gel mobility shift analyses
between M1 motif and increased amount GST-CTCF-ZFs fusion protein. In a volume of 20 μL, 20 fmol duplex probe was incubated
with GST-CTCF-ZFs fusion protein with different amount (0, 0.2, 0.4, 0.6, 1.0, 1.5, 2.0, 2.5 μg). (C) Gel mobility shift analyses of
competition of GST-CTCF-ZFs binding to the biotin-labeled M1 by an excess amount of unlabeled M1. Lane 1. No protein; Lane 2.
Incubation of GST with biotin-labeled M1 probe; Lane 3. Incubation of GST-CTCF-ZFs with biotin-labeled M1 probe; Lane 4.
Incubation of GST-CTCF-ZFs with 20 fmol biotin-labeled M1 and 4 pmol unlabeled M1 probe. (D) The sequences of CTCF binding
motif 2. (E) Gel mobility shift analysis of GST-CTCF-ZFs protein with M2 motif. Assay condition was the same as in Fig. 1B. (F) Gel
mobility shift analysis of competition of GST-CTCF-ZFs binding to the biotin-labeled M2 by an excess amount of unlabeled M2. Assay
condition was the same as in Fig. 1B. (G) Scatchard analysis of the gel shift binding of M1 to GST-CTCF-ZFs. The ratio of bound to
(not clear) free DNA is plotted versus the molar concentration of bound M1 in the reaction mixture. (H) Scatchard analysis of the gel
shift binding of M2 to GST-CTCF-ZFs. The ratio of bound to free DNA is plotted versus the molar concentration of bound M2 in the
reaction mixture. (I) Competition assays of CTCF-ZFs binding to biotin-labeled M1 oligo with different amount of unlabeled M2 oligo.
(J) Competition assays of CTCF-ZFs binding to biotin-labeled M2 oligo with different amount of unlabeled M1 oligo. (K) The binding
level of CTCF protein to CTCF binding motif 1 (M1) was quantitatively measured by qPCR using the indicated primer sets. M1
enrichment was represented as percentage of input (%). (L) The binding level of CTCF to CTCF binding motif 2 (M2) was
quantitatively measured by ChIP-qPCR using the indicated primer sets.
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competitor oligo did not displace M1 binding even at
1000-fold excess (Fig. 1I and 1J).
To conﬁrm our in vitro EMSA, we constructed two different
plasmids with insertion of either M1 or M2 CTCF binding
sites (Fig. S2). We transfected these constructs into 293T
cells, respectively, and performed in vivo chromatin
immunoprecipiation (ChIP). ChIP DNA was then examined
by quantitative real-time PCR (ChIP-qPCR) experiments.
We designed the qPCR primers in the construct at the
regions with CTCF binding site (either M1 or M2) inserted
and without CTCF binding site (Fig. S2). Our ChIP-qPCR
results showed that the CTCF was recruited to both M1 and
M2, respectively, but not to the negative region. Furthermore,
stronger binding signals were observed at M1 in contrast to
M2 (Fig. 1K and 1L), suggesting that CTCF prefers to bind to
M1 rather than M2.
To determine the critical residues in CTCF binding site
that are required for both M1 and M2 to bind to CTCF, we
have looked into CTCF binding motif M1 and M2 and
designed multiple point mutations according to the position
weight matrix score (Schmidt et al., 2012). For this purpose,
we synthesized M1 with a series of 3 bp mutations (Fig. 2A).
We performed gel shift assays to compare the binding
afﬁnity of GST-CTCF-ZFs to the wild type and various
mutated M1 (M1-Mut1 to M1-Mut7). Data suggested that,
replacement of the “TGG” with “GTT” in M1 resulted in a
drastic loss of the DNA binding ability of GST-CTCF-ZFs
(Fig. 2B, lane 2), whereas other replacements (Mut2 to Mut7)
did not alter binding signals signiﬁcantly to that of wild-type
M1 (Fig. 2B). These unexpected results indicate that “TGG”
are most critical residues for M1 binding to CTCF. We also
mutated one nucleotide or a few nucleotides within or around
the “TGG”. However, these mutations did not abolish the
binding shift of CTCF to M1 (Fig. 2C–F), except M1-Mut1.
These data suggested that “TGG” might contribute the
binding function of M1 more signiﬁcantly.
While CTCF contains 11 zinc ﬁngers domains, the
speciﬁcity and afﬁnity can be controlled by a few crucial
ﬁngers (Renda et al., 2007). To further determine which zinc
ﬁnger arrays actually bind to “TGG”, we used a web server
(http://zf.princeton.edu/) that can predict DNA-binding
speciﬁcities for C2H2-ZF-containing proteins, including
CTCF (Persikov and Singh, 2014). Our analyses suggest
that CTCF-ZFs 7–8 is critical for the M1 “TGG” binding
(Sequence logos for the generated are given in Fig. S3).
To assess the position or critical residue that is important
for M2 binding to CTCF, we made three point mutations (M2-
Mut1, M2-Mut2, and M2-Mut3) according to position weight
matrix score and performed EMSA assays (Fig. 2G). Our
data showed that mutation of any selected single base within
M2 abolished the binding of GST-CTCF-ZFs to M2 (Fig. 2H).
These results suggested that the selected single base is
required for the high-afﬁnity interaction of M2 with CTCF.
To further verify that the mutated M1 or M2 abolished the
CTCF binding of in vivo, we made several mutated con-
structs within CTCF binding sites (Fig. S2). In vivo ChIP
experiments indicated that the mutation of M1 (from “TGG” to
“GTT”) signiﬁcantly decreased the binding of CTCF to M1
(Fig. 2I) and all single mutations within M2 abolished the
binding of CTCF to M2 when compared to the control
(Fig. 2J).
Several studies have reported that the transcription factor
binding site sequence could play a role in ﬁne-tuning the
expression level of genes (Kandoth et al., 2013). For
example, binding sites might be able to modulate gene
expression as a consequence of differences in afﬁnity (Bain
et al., 2012), where high afﬁnity binding sites induce a higher
level of transcriptional activation than low afﬁnity binding
sites. In this respect, afﬁnity of different CTCF binding motifs
to CTCF-ZFs has not been determined. Herein we show that
the binding abilities of GST-CTCF-ZFs to its M1 and M2
motifs were different. The binding of GST-CTCF-ZFs to M1 is
much stronger than to M2. Importantly, similar conclusion
was obtained with ChIP experiments (Fig. 1K and 1L).
When we initially incubated the GST-CTCF-ZFs with the
oligos from either M1 or M2 core motif, we failed to see a
clear shift after EMSA assay (Data not shown). Lobanenkov
et al. suggested that additional DNA ﬂanking outside the
CTCF recognition motifs are required for tight binding but the
exact sequence requirement for this ﬂanking DNA may not
be as strict as that of the CCCTC motifs (Lobanenkov et al.,
1990). In combination with our results, we expect that the
binding of CTCF to M1 and M2 in vitro need not only the core
recognition sequence but also a few bps outside DNA. By
b Figure 2. Alteration of single/few nucleotide(s) in M1 or M2
dramatically impact(s) the binding of CTCF. (A) The wild-
type (WT) and 3 bp mutant (Mut) sequences of CTCF binding
M1. (B) Comparisons of the binding capacity of WT M1 and
mutant M1. The binding of GST-CTCF-ZFs fusion protein to WT
M1 (lane 1), to Mut 1 (from TGG to GTT) (lane 2), to Mut 2 (from
TGC to TAA) (lane 3), to Mut 3 (from CCT to AAA) (lane 4), to
Mut 4 (from TGC to GTA) (lane 5), to Mut 5 (from TGG to GTT)
(lane 6), to Mut 6 (from CCA to AAC) (lane 7), and to Mut 7
(from TCT to AAG) (lane 8). (C) The WT and 2 bp Mut
sequences of CTCF binding M1. (D) Comparisons of the
binding capacity of WT M1 and 2 bp Mut M1. The binding of
GST-CTCF-ZFs fusion protein to WT M1 (lane 1), to Mut 8 (from
TG to GT) (lane 2), to Mut 9 (from GG to TT) (lane 3), and to Mut
10 (from GT to TG) (lane 4). (E) The WT and 1 bp Mut
sequences of CTCF binding M1. (F) Comparisons of the
binding capacity of WT M1 and 1 bp Mut M1. The binding of
GST-CTCF-ZFs fusion protein to WT M1 (lane 1), to Mut 11
(from T to G) (lane 2), to Mut 12 (from G to T) (lane 3), and to
Mut 13 (from G to A) (lane 4). (G) The WT and 1 bp Mut
sequences of CTCF binding M2. (H) Comparisons of the
binding capacity of WT M2 and 1 bp Mut M2. The binding of
GST-CTCF-ZFs fusion protein to WT M2 (lane 1), to Mut 1 (from
A to T) (lane 2), to Mut 2 (from T to G) (lane 3), and to Mut 3
(from C to A) (lane 4). (I) Comparisons of the binding capacity of
CTCF to both WT M1 and Mut M1 by ChIP-qPCR. (J) Compar-
isons of the binding capacity of CTCF to both WT M2 and Mut
M2 by ChIP-qPCR.
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referring to CTCF binding motif probes that detected by
ChIP-seq (Xiao et al., 2015), we synthesized 30 bp biotin
labeled double-strand M1 (5′-CTTTTTGGTGCCCTCTGCT
GGCCAGTTTAG-3′) and 20 bp biotin labeled double-strand
M2 (5′-CTTTTGGAACTGCAGTTTAG-3′) that including the
core motif and additional ﬂanking DNA sequence (5′-CTTTT
and GTTTAG-3′) and tested their binding abilities to CTCF-
ZFs in both in vitro and in vivo assays.
CTCF represses cancer cell growth and clonogenicity and
has been classiﬁed as a candidate tumor suppressor gene
(Rasko et al., 2001). Recent studies have identiﬁed muta-
tions of human CTCF binding sites in various human cancer
types including Wilms’ tumor, leukaemia (Mullighan et al.,
2011). Thus, mutation of CTCF binding sites at speciﬁc loci
may dysregulate the expressions of tumor suppression
genes or oncogenes, thereby contributing to the malignant
phenotype (Filippova et al., 2002). In this study, we found
that several mutations of CTCF binding sites abolished the
binding of CTCF-ZFs to the mutated sites both in vitro and
in vivo. These mutations are likely to exist in the genome of
some cancer types. To enrich our knowledge for the roles of
all base pairs in CTCF binding sites, a genetic mutation
screening might be necessary for us to implement the
mutations in a variety of patterns in the future.
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